OWACX
Price
$27.03
Change
-$0.01 (-0.04%)
Updated
Sep 5 closing price
Net Assets
3.43B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

OWACX vs RGEBX

Header iconOWACX vs RGEBX Comparison
Open Charts OWACX vs RGEBXBanner chart's image
Old Westbury All Cap Core
Price$27.03
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets3.43B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
OWACX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OWACX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OWACX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. OWACX (3.43B). OWACX (0.00) and RGEBX (0.00) have matching dividends . OWACX was incepted earlier than RGEBX: OWACX (28 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than OWACX (0.96). OWACX is a more actively managed with annual turnover of: 41.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than OWACX: RGEBX (250) vs OWACX (1000). RGEBX annual gain was more profitable for investors over the last year : 17.59 vs. OWACX (1.77). RGEBX return over 5 years is better than : 38.71 vs. OWACX (30.32).
OWACXRGEBXOWACX / RGEBX
Total Expense Ratio0.961.0988%
Annual Report Gross Expense Ratio0.961.0988%
Fund Existence28 years11 years-
Gain YTD6.92215.39845%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.43B332B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.7717.5910%
Returns for 3 years30.9557.6154%
Returns for 5 years30.3238.7178%
Returns for 10 years101.5191.44111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd